Armata Pharmaceuticals (ARMP) Earnings Date & Reports

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ARMP is expected to report earnings to rise 95.00% to -38 cents per share on August 13

Armata Pharmaceuticals ARMP Stock Earnings Reports

Q2'25

Est.

$-0.39

Q1'25

Missed

by $0.04

Q4'24

Beat

by $0.06

Q3'24

Beat

by $0.13

Q2'24

Beat

by $0.12

The last earnings report on May 14 showed earnings per share of -20 cents, missing the estimate of -15 cents. With 551.00 shares outstanding, the current market capitalization sits at 72.39M.

View a ticker or compare two or three

Compare

ARMP